Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/III, Multicenter, Observer-Blinded, Randomized, Active Controlled Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus in 1 to 45 Years Old South Africans

NCT07304284 is registered in ClinicalTrials.gov with International Vaccine Institute as lead sponsor.

NCT NCT07304284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07304284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/III, Multicenter, Observer-Blinded, Randomized, Active Controlled Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus in 1 to 45 Years Old South Africans
Lead sponsor
International Vaccine Institute
Phase
Phase 3
Overall status
Recruiting
Start date
October 31, 2025
Completion date
February 28, 2027
Enrollment
2,824 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cholera vaccination